Page 1 of 6
University of Cincinnati, College of Nursing
OBN Approver Unit (OBN-011-93)
Application - Faculty Directed CNE Activity
Title of Offering: 12th Annual State of the Art Management of Infectious Diseases
Date of Offering: March 16, 2013
Sponsor (Facility/Organization): PA/MidAtlantic AIDS Education and Training Center
Address: University of Cincinnati Medical Center, Cincinnati, OH 45267-0405
Contact Person: Yolanda Wess, RN, BSN, ACRN
Weekday Phone: 513-584-2422
Contact Hours Requested: _4.5 (NOTE: Please review for APN pharmacy credit also.)__
(To calculate contact hours, add the number of minutes of actual learning time and divide by 60.)
Category A only of contact hours: _______ (if applicable)
Educational Design Criteria
Part A
A. Resources
1. Person Administratively Responsible for Offering
Name: Yolanda Wess
Title: PAMA/AETC Site Director
Address: University of Cincinnati, Holmes Bldg., Rm. 3103
Cincinnati, OH 45267-0405
Weekday Phone: 513-584-2422
Education: BSN, Graduate Certificate in Medical Education, Curriculum and Instruction, University of
Cincinnati College of Education, Human Services and Criminal Justice, currently working on Masters of
Education in Medical Education
Professional Qualifications: AIDS Clinical Trials Nurse 1998-2000; Hospice Nurse with AIDS
patients 1991-96; CQI and Community Outreach Staff at Clinical HIV Care Unit, 2000-2003;
Site Director AIDS Education and Training Center Site at UC, 2003-present.
2. Planning Committee (Must include 2 RNs, one with a BSN, and 1 LPN if LPNs are included in the target
audience which includes audiences specified generically as “nurses”)
Name: Yolanda Wess
Education: BSN, Graduate Certificate in Medical Education (Curriculum and Instruction)
Current Position: Site Director, University of Cincinnati LPS, PAMAAETC
Professional Qualifications: See above
Name: Jan Stockton
Education: MSN, APRN
Current Position: Prin. Research Asst., University of Cincinnati Medical Center, AIDS Clinical Trials Unit;
New Patient Intake coordinator, Infectious Disease Center
Professional Qualifications: 20+ years of experience in providing direct patient care to persons living
with HIV/AIDS; Multiple presentations to health care professionals on various topics related to
HIV/AIDS, including pathophysiology, diagnosis and treatment, opportunistic infections and
complications, and psychosocial issues. Certified as Clinical Nurse Specialist in Medical-Surgical
Nursing by American Nurses Credentialing Center; Advanced AIDS Certified RN, HIV/AIDS
Nursing Certification Board
Page 2 of 6
Name: Nancy Peter
Education: BA
Current Position: Program Trainer, University of Cincinnati LPS, PAMAAETC
Professional Qualifications: 10 yrs experience in planning and coordination of health related programs,
including 3 years of HIV/AIDS programming, has presented topics on basic HIV educational programs for
health care professionals throughout Ohio.
B. Target Audience and Needs Assessment
Check those that apply: __X_ RNs ___ LPNs ___ other (specify)___social workers____X_______
Projected number of: __20__ RNs ______ LPNs
Briefly describe what led you to identify a need for and plan this offering:
Responses to needs assessments on prior program evaluations and requests from RN’s and advanced
practice nurses attending our clinical training programs
C. Faculty Credentials (In addition to listing faculty names for Part B of application form, complete the following
information for each faculty member. Do not send complete resumes, vita, or biographies.)
Name: Robert A. Salata, MD
Education: M.D.
Current Position: Professor of Medicine, Chief of the Division of Infectious Diseases and HIV Medicine
Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve
University School of Medicine, Cleveland OH
Professional Qualifications specific to topic being presented: Dr. Salata is interested in HIV-1 and sexually
transmitted infections, infectious diseases, nosocomial infections, orthopaedic infections, sepsis, transplant
infections, travelers' medicine. His research includes clinical trials of antiretrovirals and immunomodulators
in HIV-1 infection as well as epidemiological studies and interventions associated with HIV-1 prevention.
Name: Carl Fichtenbaum, MD
Education: M.D.
Current Position: Professor of Clinical Medicine, Division of Infectious Diseases, University of Cincinnati
College of Medicine, Cincinnati, OH
Professional Qualifications specific to topic being presented: Dr. Fichtenbaum's expertise is in clinical research
in infectious diseases, in particular opportunistic infections of HIV-infected individuals. Dr. Fichtenbaum is
in charge of clinical research for the infectious diseases divisionan. He is board certified by the American
Board of Internal Medicine and Infectious Diseases, and American Board of Pediatrics. Dr. Fichtenbaum
has been elected to the American College of Physicians, American Academy of Pediatrics, Infectious
Diseases Society of America. His published works include approximately 60 articles, 45 abstracts and
various reviews, book chapters and letters.
Name: Judith Feinberg, MD
Education: M.D.
Current Position: Professor of Clinical Medicine, Division of Infectious Diseases, University of Cincinnati
College of Medicine, Cincinnati, OH
Professional Qualifications specific to topic being presented: Judith Feinberg, MD, is well known for her
clinical research in HIV infection and for her expertise in designing and conducting multi-center treatment
trials. As an American Academy of HIV Medicine-credentialed HIV specialist, she serves as the coprincipal investigator of the NIH-funded AIDS Clinical Trials Unit and as Leader of the Clinical Research
Site (CRS) at the University of Cincinnati ACTU. Feinberg joined the department of internal medicine at
UC in 1995. She specializes in HIV/AIDS, HIV resistance, antiretroviral therapy and clinical trials
methodology.
Page 3 of 6
Name: Peter Hunt, MD
Education: M.D.
Current Position: Assistant Professor of Medicine, HIV Division, San Francisco General Hospital, San
Francisco, CA
Professional Qualifications specific to topic being presented: Dr. Hunt’s primary research focus is on the
inflammatory consequences of HIV infection. His clinic-based translational research program seeks to
understand the determinants of persistent immune activation both in the presence and the absence of
antiretroviral therapy, and to assess the impact of immune activation on clinical outcomes. He also
collaborates extensively with a multi-disciplinary team of investigators to assess the role of HIV-associated
inflammation in non-AIDS-associated morbidities (i.e., cardiovascular disease) and conducts pilot clinical
trials of novel immune-based interventions designed to decrease immune activation.
Name: Robert A. Bonomo, MD
Education: M.D.
Current Position: Professor of Medicine, Pharmacology, Molecular Biology and Microbiology, University
Hospitals, Case Medical Center, Cleveland OH
Professional Qualifications specific to topic being presented: Dr. Bonomo currently serves on the AntiInfective Utilization Subcommittee, Pharmacy and Therapeutics Committee, University Hospitals of
Cleveland and the Pharmacy and Therapeutics Committee Louis Stokes Veterans Affairs Medical Center.
The primary focus of his current research is to understand the genetic and amino acid sequence
determinants of ß-lactamases, the enzymes that inactivate ß-lactam antibiotics and he has published
extensively in this area.
Name: David Alain Wohl, MD
Education: M.D.
Current Position: Associate Professor of Medicine, Division of Infectious Diseases, University of North
Carolina, Chapel Hill NC
Professional Qualifications specific to topic being presented: Dr. Wohl is site leader of the UNC AIDS Clinical
Trials Unit at Chapel Hill and codirects HIV services for the North Carolina Department of Correction. In
2011, Dr. Wohl also became director of the North Carolina AIDS Education and Training Center (AETC).
Dr. Wohl's research interests fall into two major areas: the metabolic complications of HIV and its
therapies, and the nexus between incarceration and the HIV epidemic. He has chaired several related AIDS
Clinical Trials Group (ACTG) studies and serves as a member of the Department of Health and Human
Services (DHHS) HIV treatment guidelines panel and the NIH Behavioral and Social Consequences of
HIV study review section.
D. Identify adult leaning principles used for planning and implementation of offering.
Experience-based presentation using an interactive format in which feedback is encouraged
Subject matter has direct application and relevance to job and to profession
E. Physical facilities (where offering being held)
Name: Kingsgate Marriott Conference Center
Address: Cincinnati, OH
Description: Selected venue is handicapped-accessible and spacious enough to comfortably
accommodate minimum 100 adults.
F. Co-sponsorship (If you are co-sponsoring, please answer numbers 2 and 3, if not check number 1).
1. ______ this offering will not be co-sponsored.
2.
_X
This offering will be co-sponsored with
Name: University of Cincinnati Medical Center, Department of Internal Medicine,
Infectious Disease Division
Address: Cincinnati, OH
Page 4 of 6
3. As the approved provider, we will maintain responsibility for meeting and maintaining OBN
standards. I have provided a copy of the written agreement with the co-sponsor(s) which
outlines the above. __YW_______(Initial)
G. Evaluation of achievement of program objectives and teaching effectiveness of faculty.
1. Attach a copy of the evaluation tool(s).
2. How will the evaluation tool(s) be used?
Included in participant packet, completion/submission required before CE certificate is
received. Feedback will be summarized and retained on file, with a copy sent to presenter.
H. Verification of Attendance - Include a completed sample of the certificate of attendance.
The certificate shall include: space for name of attendee; the title of the program; the date of the
program; the name of the provider (your organization) of the CNE activity; the name of the OBN
Approver and OBN Approver number; and the number of contact hours earned. The following
statement as required meets criteria for identifying the OBN Approver and OBN Approver
Number.
This offering has been approved by the Ohio Board of Nursing through the OBN
Approver Unit at the University of Cincinnati College of Nursing (OBN-011-93).
I. Record Keeping System
As a provider, we will retain:
a. A complete copy of all application data;
b. All correspondence with the UC College of Nursing;
c. A list of all attendees who were awarded contact hours for each date of the CNE offering
that includes the number of contact hours awarded;
d. An evaluation summary for each date of the offering
e. Any changes made to the program during its approval period.
The records must be maintained in a retrievable file, which is safe, secure and accessible to only
authorized personnel, for six years. Initial here to indicate that you will retain records, as
described: ___YW______.
Describe the method that a participant would use to obtain a replacement certificate of attendance.
Contact the University of Cincinnati AIDS Education and Training Center office.
J. Attach a copy of advertising material (announcement/brochure/letter). A draft is acceptable for
approval process, but FINAL COPY MUST BE SUBMITTED for our Approver Unit records.
Part B – Program Details
Complete the next page or attach your own form identifying behavioral objectives of offering; content
and schedule; faculty; faculty/participant ratio and teaching methods.
Page 5 of 6
Program Details
OBJECTIVES
CONTENT (Topics)
List objectives in
behavioral terms
List each topic area to be covered
and outline of content for each obj.
Discuss the implications that 1. Epidemiologic Synergy
STDs and HIV/STD co2. Genital Herpes
infection have on the
3. Syphilis
management of these
4. Trichomoniasis
diseases
5. Gonorrhea/ Chlamydia/Pelvic
TIME FRAME
FACULTY
State # minutes for
each objective
TEACHING METHOD
Describeteaching method
used for each objective
PowerPoint, handouts,
discussion
45
Robert A. Salata, MD
45
Carl Fichtenbaum, MD
Judith Feinberg, MD
Q&A
Inflammatory Disease
6. Future Approaches and Advice for
Review current guidance for
monitoring and prescribing
treatment for individuals at
risk for HIV infection,
including sero-discordant
couples hoping to conceive
Explain new evidence
regarding inflammatory
processes of HIV infection
and long term complications
and treatment
Describe the current
understanding of infections
that continue to present
difficult management issues
and epidemiological
concerns
Clinicians
1. Pre-exposure prophylaxis (PreP)
a. Rationale
b. Ideal drug candidate
2. Current status of clinical trials
3. Potential concerns for PreP
4. Interim CIC Guidelines and Evaluation
for PreP
1. Chronic inflammation and HIV
pathogenesis
2. Causes of persistent immune
activation and inflammation
a. HIV replication
b. Microbial translocation
c. Coinfections
3. Immune activation and co-morbidity
a. Cardiovascular disease
b. Thromboembolic disease
c. Type II diabetes
d. Cancer
e. Neurocogitive dysfunction
f. Frailty
1. Infectious diseases epidemiology
2. Antibiotic resistance,
3. Emerging pathogens and pathogenesis
4. Therapeutics,
PowerPoint, Lecture,
handouts, discussion,
Q&A
PowerPoint, Lecture,
handouts, discussion,
Q&A
45
40
Peter Hunt, MD
Robert A. Bonomo, MD
PowerPoint, Lecture,
handouts, discussion,
Q&A
Page 6 of 6
Identify key considerations
when designing treatment
regimens for first line
therapy, treatment
experienced and salvage
therapy
Evaluation
03/02
lte/CE/OBNoffapp.doc
1. Timing of ART initiation in treatment naive patients
2. Guidance on new regimens
3. Special Considerations for
a. older patients
b. women of childbearing age
c. virologic failure and multidrug
resistance
75
5 minutes
David Alain Wohl, MD
Panel: Robert A. Bonomo, MD;
Judith Feinberg, MD
Carl Fichtenbaum, MD
Peter Hunt, MD
Robert A. Salata, MD
PowerPoint, Lecture,
handouts, discussion,
Case-Based Panel
Discussion
Q&A